Breast Imaging Market Insights:
Breast Imaging Market is projected to be worth USD 9.47 Billion by 2030, registering a CAGR of 8.17% CAGR during the forecast period (2022-2030), the market was valued at USD 4.67 Billion in 2021. The non-ionizing breast imaging segment of the market is expected to grow at the highest CAGR during the forecast period. In the regional segment, Asia Pacific is expected to dominate the growth of the Breast Imaging Market.
Breast Imaging Market Dynamics:
Breast imaging is a branch of diagnostic radiology that deals with imaging the breasts for either screening or diagnostic reasons in medicine. Several technologies are used in different breast imaging techniques. Technologies used in breast imaging are Mammography, Breast Ultrasound, MRI, ABUS, MBI, CBCT, and PET-CT Optical Imaging.
Driver:
One of the key factors that are considerably fueling the growth of the breast imaging market is the rising incidence of breast cancer. Furthermore, a rising number of conferences worldwide on early diagnosis and screening, rapid technological advancements in breast screening, and excellent cancer screening reimbursement policies are the factors driving the growth of the breast imaging market.
Restraints:
Ionizing radiation is used in breast imaging procedures such as digital breast tomosynthesis (DBT), digital mammography (DM), whole-breast computed tomography (WBCT), molecular breast imaging (MBI), contrast-enhanced mammography (CEM), breast-specific gamma imaging (BSGI), and positron emission mammography (PEM). Consequently, increasing radiation exposure risk is expected to hamper the breast imaging market.
Opportunity:
The expansion of the breast imaging market is expected to benefit from the increase in research and development activities. The growth rate of the breast imaging market is probable to accelerate in the future along with this expansion of technical advancement in the field of medical devices. Further, emerging markets in the Asia Pacific are expected to boost market expansion as breast cancer is one of the most common cancer.
COVID-19 Analysis of Breast Imaging Market:
Several industries were negatively impacted by the COVID-19 epidemic. Additionally, it had a substantial influence on breast imaging treatments. Market demand has been hampered by lockdowns and other restrictions imposed by governments all over the world. To stop the virus from spreading, governments have also put regulations in place that postpone elective and non-urgent medical procedures. Additionally, a significant decrease in breast imaging diagnoses was caused by the virus’s fear of transmission, particularly during COVID-19’s first wave in 2020. Breast Cancer Now (UK) data from September 2020 claims that COVID-19 has resulted in over 9,86,000 women in the UK skipping their breast screening visits. Compared to data from 2019, there was a 64 percent fall in mammography, a 47.7% decline in breast ultrasound, and a 41.7% decline in breast MRI cases in Turkey, according to research published in the Eurasian Journal of Medical Investigation in 2020. Thus, COVID-19 had a significant negative impact on the breast imaging industry.
Breast Imaging Market Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 9.47 |
| CAGR (2022-2030) | 8.17% |
| By Technology | Ionizing Technology – Full-Field Digital Mammography (FFDM), 3D Breast Tomosynthesis, Positron Emission Tomography/Computed Tomography (PET/CT), Molecular Breast-Specific Gamma Imaging (MBI/BSGI), Computed Tomography (CT), Positron Emission Mammography (PEM), Analog Mammography
Cone Beam Computed Tomography (CBCT) – Non-Ionizing Technology, Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography, Optical Imaging |
| By End-User | Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers |
| By geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) The Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Hologic, Inc., GE Healthcare, Canon Inc., Siemens AG, Koninklijke Philips N.V., Carestream Health, Inc, Planmed Oy, Hitachi, Ltd., Dilon Technologies Inc., CMR Naviscan Corporation, FUJIFILM Holdings Corporation, Aurora Healthcare US Corp, SonoCine Inc |
Breast Imaging Market Segment Analysis:
By Technology
The global breast imaging market is divided into non-ionizing and ionizing breast imaging methods based on technology. During the projected period, the non-ionizing breast imaging category is anticipated to develop at the greatest CAGR. The non-ionizing breast imaging segment is further divided into optical imaging, breast ultrasound, automated whole-breast ultrasound, breast MRI, and breast thermography. The technological advantages of non-ionizing breast imaging over ionizing breast imaging technologies, such as increased generation of anatomical details for diagnosis, fewer false positive test results, and high sensitivity to small breast lesions in women with dense breast tissues, are attributed to the growth in this breast imaging market segment.
By End Use
The end-use segment of the breast imaging market is trifurcated into hospitals, diagnostic imaging centers, and Ambulatory surgical centers. In 2021, the hospital sub-segment is anticipated to hold the highest market share for breast imaging. The main drivers of hospitals’ dominance include growing investments in the development of healthcare infrastructure and rising purchasing power. Further, the availability of operating and diagnostic rooms with modern equipment, and better health insurance for hospital-based healthcare services are the factors expected to supplement the growth of the market. The other sub-segments of the market such as diagnostic imaging centers and Ambulatory surgical centers are expected to supplement the growth of the breast imaging market during the forecast period.
By Region
The regional segment includes regions such as Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The Asia Pacific is estimated to be the fastest growing region of the breast imaging sector. The rising incidence of breast cancer and rising healthcare expenses are the main drivers of the breast imaging market’s expansion in the Asia Pacific. The demand for breast imaging is also anticipated to increase due to the growing number of awareness campaigns for breast cancer early detection and the significant government investment in breast cancer research studies in numerous APAC nations. Asia experienced 911,014 new cases of breast cancer overall in 2018, according to GLOBOCAN 2018, and by 2030, that number is expected to increase by 229,650.
Breast Imaging Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Technology launches have accelerated the growth of the Breast Imaging Market. Key players in the market include-
- Hologic, Inc.
- GE Healthcare
- Canon Inc.
- Siemens AG
- Koninklijke Philips N.V.
- Carestream Health, Inc
- Planmed Oy
- Hitachi, Ltd.
- Dilon Technologies Inc.
- CMR Naviscan Corporation
- FUJIFILM Holdings Corporation
- Aurora Healthcare US Corp
- SonoCine Inc.
Recent development
- In more than 50 centers across the United States, Texas-based Soil Mammography’s SmartCurve breast imaging technique was introduced in September 2018. The newly created gadget provides a curved compression surface that is similar to the form of the breast, increasing patient comfort.
- To raise awareness among patients about breast disorders, breast imaging, and emerging trends, the Society of Breast Imaging (SBI) announced in October 2018 that it has partnered with Oxford University Press to publish the journal of breast imaging.
- MammoAssist, a tool powered by artificial intelligence from Telerad Tech, was released in October 2018 to identify breast cancer at an early stage.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Technology Picture of Breast Imaging
- Global Breast Imaging Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Breast Imaging Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Therapeutic
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Technology Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Breast Imaging Market demand
- Post-Covid Impact on Breast Imaging Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Breast Imaging Market Segmentation, Revenue (USD Billion), (2022-2030)
- By Technology
- Ionizing Technology
- Full-Field Digital Mammography (FFDM)
- 3D Breast Tomosynthesis
- Positron Emission Tomography/Computed Tomography (PET/CT)
- Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
- Computed Tomography (CT)
- Positron Emission Mammography (PEM)
- Analog Mammography
- Cone Beam Computed Tomography (CBCT)
- Non-Ionizing Technology
- Breast Ultrasound
- Breast MRI
- Automated Whole-Breast Ultrasound
- Breast Thermography
- Optical Imaging
- By End Use
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Ionizing Technology
- By Technology
- Global Breast Imaging Market Overview, By Region
- North America Breast Imaging Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Technology
- By End Use
- Canada
- Mexico
- US
- Europe Breast Imaging Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Breast Imaging Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Breast Imaging Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Breast Imaging Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Breast Imaging Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Breast Imaging Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Hologic, Inc.
- Business Overview
- Business Financials (USD Billion)
- Technology Category, Source, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- GE Healthcare,
- Canon Inc.
- Siemens AG
- Koninklijke Philips N.V.
- Carestream Health, Inc
- Planmed Oy
- Hitachi, Ltd.
- Dilon Technologies Inc.
- CMR Naviscan Corporation
- FUJIFILM Holdings Corporation
- Aurora Healthcare US Corp
- SonoCine Inc.
- Hologic, Inc.
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.